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Abstract
Background: Coliform mastitis is a symptom of postpartum dysgalactia syndrome (PDS), a multifactorial infectious
disease of sows. Our previous study showed gene expression profile change after bacterial challenge of porcine
mammary epithelial cells (PMECs). These mRNA expression changes may be regulated through microRNAs (miRNAs)
which play critical roles in biological processes. Therefore, miRNA expression profile was investigated in PMECs.
Results: PMECs were isolated from three lactating sows and challenged with heat-inactivated potential mastitis-causing
pathogen Escherichia coli (E. coli) for 3 h and 24 h, in vitro. At 3 h post-challenge with E. coli, target gene prediction
identified a critical role of miRNAs in regulation of host immune responses and homeostasis of PMECs mediated by
affecting pathways including cytokine binding (miR-202, miR-3277, miR-4903); IL-10/PPAR signaling (miR-3277, miR-
4317, miR-548); and NF-ĸB/TNFR2 signaling (miR-202, miR-2262, miR-885-3p). Target genes of miRNAs in PMECs
at 24 h were significantly enriched in pathways associated with interferon signaling (miR-210, miR-23a, miR-1736) and
protein ubiquitination (miR-125, miR-128, miR-1280).
Conclusions: This study provides first large-scale miRNA expression profiles and their predicted target genes in PMECs
after contact with a potential mastitis-causing E. coli strain. Both, highly conserved miRNAs known from other species
as well as novel miRNAs were identified in PMECs, representing candidate predictive biomarkers for PDS. Time-dependent
pathogen clearance suggests an important role of PMECs in inflammatory response of the first cellular barrier of the
porcine mammary gland.
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Background
Coliform mastitis (CM) represents one of the most im-
portant cardinal symptoms of postpartum dysgalactia
syndrome (PDS) in sows [1]. This multifactorial infec-
tious disease has high economic relevance for the pig in-
dustry, because both postpartum sows and their piglets
can be critically affected by mastitis and lactation failure
[2]. Husbandry and management conditions, pathogen
contamination, and genetic predisposition are suspected
etiological factors that contribute to PDS [3]. Gram-negative
pathogens such as Escherichia coli (E. coli) are most com-
monly isolated from milk of PDS-positive sows, but are
found in non-affected sows as well [4, 5]. Therefore, it is
unclear which determinants result in development of sub-
clinical or clinical signs of infection within 12–48 h postpar-
tum, or otherwise preserve clinical health.
Lipopolysaccharide (LPS) endotoxin is a pathogenic
factor of E. coli and can induce acute and severe inflam-
mation in sows and other animal species [6]. Our previ-
ous study showed that E. coli induce a fast and strong
inflammatory response in porcine mammary epithelial
cells (PMECs) [7]. In these cells, bacterial challenge
strongly upregulates mRNA expression of genes encod-
ing cytokines, chemokines, and cell adhesion molecules.
Furthermore, these changes suggest rapid activation of
other immune-competent cells mediating pathogen
clearance and host homeostasis through interleukin 1
beta (IL1B) and tumor necrosis factor (TNF) expression
[7]. Therefore, cellular as well as molecular factors may
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be highly relevant to animals’ susceptibility to intramam-
mary infection and mastitis.
MiRNAs are small non-coding RNA molecules (∼22
nucleotides long) and are highly conserved across higher
eukaryotic species and can modulate host immune
responses [8] as well as are involved in a variety of
signaling pathways and biological processes, such as
development, cell proliferation, cell differentiation, cell
death, metabolism, and disease [9].
In epithelial cells, miRNAs can modulate production
and release of cytokines/chemokines and expression of
adhesion and costimulatory molecules [10]. According
to different microbe-associated molecular patterns
(MAMPs) from bacteria, innate and adaptive host im-
mune responses are activated through stimulation of
pattern recognition receptors (PRRs) [11]. In bovine
mammary epithelial cells, E. coli affect expression of
miR-184, miR-24-3p, miR-148, miR-486, and let-7a-5p,
which target genes involved in developmental/cellular
processes, biological regulation, cell growth, and death
[12]. Furthermore, miR-142-5p, miR-223, miR-2898,
miR-16, and miR-181a are potential markers for mastitis
in cattle [12–16].
In contrast, the function of miRNAs in innate and
adaptive immunity of porcine mammary glands has not
yet been described. Therefore, our study focused on
miRNA expression changes in PMECs induced by a po-
tential mastitis-causing E. coli strain isolated from milk
of PDS-positive sows. We characterized miRNA expres-
sion differences in PMECs at 3 h and 24 h after chal-
lenge with heat-inactivated E. coli to investigate and to
compare early and late phase of immune response since
specific kinetics and extents of global changes in the
transcriptome of bovine mammary epithelial cells were
found in a study with comparable experimental design
[17]. The response of PMECs was determined by com-
paring miRNA expression profiles between pathogen-
challenged and unchallenged control groups. Together
with our previous mRNA expression profiles, miRNA
expression data were then integrated based on pairwise
correlations and computational target predictions to
identify potentially affected signaling pathways. Finally,
we performed selective analysis of the most and stron-
gest affected biological processes, molecular functions,
and Kyoto Encyclopedia of Genes and Genomes (KEGG)/
canonical pathways to investigate the role of miRNAs in
pathogen clearance of PMECs.
Results
Effects of E. coli challenge on miRNA expression in PMECs
MiRNA expression profiling was performed at 3 h post-
challenge (hpc) and 24 hpc of PMECs with E. coli in
comparison to unchallenged control cells using Affyme-
trix GeneChip miRNA 3.0 arrays. After quality control
and filtering of raw data, 3277 probesets corresponding
to 1332 mature miRNA sequences were further ana-
lyzed. Top10 most highly expressed miRNAs (normal-
ized log2 signal intensity >13) in unchallenged PMECs
are miR-23a, miR-24, miR-24a, miR-24-3p, miR-27a,
miR-31, miR-31b, miR-221, miR-222, and miR-222a.
Compared with other published results in the same cell
type, some miRNAs which are highly expressed in pig,
were also found as highly expressed in cattle and mice,
e.g. miR-26a, miR-205, miR-221, and miR-222 [12, 18, 19].
Furthermore, miR-21, miR-22-3p, miR-27b, miR-27a-3p,
miR-31, miR-92a, miR-182, and miR-191 are highly
expressed in porcine as well as bovine mammary epithelial
cells [12, 18].
Statistical analysis identified 143 significantly differen-
tially expressed (DE) probesets (p < 0.05; fold change
>1.5 or < −1.5) corresponding to 102 mature miRNA se-
quences (41 up- and 61 downregulated) at 3 hpc with E.
coli when compared with unchallenged controls (Fig. 1;
Additional file 1). At 24 hpc with E. coli, 299 signifi-
cantly DE probesets corresponding to 188 mature
miRNA sequences (80 up- and 108 downregulated) were
identified as compared to unchallenged controls (Fig. 1;
Additional file 1). Approximately 70% of significantly DE
miRNAs at 3 hpc with E. coli (71 mature miRNA se-
quences; 28 up- and 43 downregulated) also differed at
24 hpc with E. coli (Fig. 1; Additional file 1). In addition,
31 mature miRNA sequences (13 up- and 18 downregu-
lated) were significantly DE only at 3 hpc with E. coli. In
contrast, 117 mature miRNA sequences (52 up- and 65
downregulated) were significantly DE only at 24 hpc
Fig. 1 Differentially expressed mature miRNAs following pathogen
stimulus. Venn diagram showing miRNAs DE in PMECs at 3 hpc and
24 hpc with E. coli (p < 0.05; fold change >1.5 or < −1.5; N = 3),
compared to unchallenged controls. Numbers in the intersecting
circles represent miRNAs that were commonly regulated at both
challenge times
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with E. coli (Fig. 1; Additional file 1). Some of these miR-
NAs are not yet annotated in Sus scrofa. As concern to
this point, we compared these miRNA sequences with
Sus scrofa miRNA in miRBase (http://www.mirbase.org)
and alignment with pig genome (Sus scrofa 10.2
download from NCBI: http://www.ncbi.nlm.nih.gov/ on
1.9.2015) and added in Additional file 1 in the column
of pig chromosome and position. On the basis of the top
100 significantly DE miRNAs after pathogen challenge, a
heat map was generated to identify distinguishable
miRNA expression profiles between short-term (3 hpc)
and long-term (24 hpc) challenge with E. coli compared
to unchallenged controls (0 hpc) (Fig. 2). Hierarchical
clustering analysis determined similar patterns in miRNA
expression profiles of both pathogen-challenged groups
compared to unchallenged control group (Fig. 2).
Prediction of miRNA targets identifies biological processes
and molecular functions that differ at 3 hpc and 24 hpc
with E. coli
Pairwise correlation coefficient analysis was performed
to evaluate associations of expression levels between 442
significantly DE miRNA probesets and 1345 significantly
DE mRNA probesets (previously identified by Jaeger et al.
[7]). In total, 36,610 miRNA–mRNA pairs were significantly
negatively correlated (p < 0.05) and in silico predicted as
functionally linked. TargetScan and RNAhybrid software
were used to further filter predicted miRNA–mRNA pairs
by setting the threshold for microRNA:target duplex energy
to −25 kcal/mol. Finally, we identified 135 miRNA–mRNA
pairs corresponding to 34 mature miRNA sequences and 71
genes at 3 hpc with E. coli (Table 1; Additional file 2). At
24 hpc with E. coli, 531 miRNA–mRNA pairs correspond-
ing to 67 mature miRNA sequences and 214 genes were
filtered (Table 2; Additional file 3).
Gene ontology (GO) analysis identified biological pro-
cesses and molecular functions predicted for target
genes of DE miRNAs. Predicted target genes of up- and
downregulated miRNAs in PMECs at 3 hpc with E. coli
were significantly associated with negative regulation of
biosynthetic processes, metabolic processes, and tran-
scription (ARID5B, BCOR, BMP2, CDC6, GLI3,
HELLS, ID4, ITGAV, PPARG, and RNF2); lipid storage
(ITGAV, NFKBIA, and PPARG); cell differentiation
(GLI3, ID4, ITGAV, JAG1, NFKBIA, and PPARG); and
regeneration (JAK2, LIFR, PLAUR, and PPARG) (Fig. 3a;
Additional file 4). Most genes were predicted targets of
predominantly miR-101, miR-125a-3p, miR-202, miR-
2262, miR-29a, miR-29b, miR-30b-star, and miR-3277
(Additional file 4).
Fig. 2 Heat map and hierarchical clustering analysis of the top 100 DE miRNA probesets. Heat map based on processed array signals (Lsmean values
log2-transformed; p < 0.05; fold change >1.5 or < −1.5) from PMECs at 3 hpc and 24 hpc with E. coli, compared to unchallenged controls (0 hpc). Red
indicates higher relative expression and blue indicates lower relative expression. Hierarchical clustering dendrogram (ward.D2 method) reveals a
distinguishable miRNA expression profile among samples
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Molecular functions influenced by predicted target
genes of up- and downregulated miRNAs in PMECs at 3
hpc with E. coli included cytokine receptor activity and
cytokine binding (IFNAR2, IL10RB, IL1RAP, and LIFR);
transcription repressor activity (ARID5B, BCOR, BMP2,
ID4, PPARG, and RNF2); chromatin binding (CDC6,
GLI3, HELLS, and RNF2); and heat shock protein
binding (BCOR, DNAJA1, and NFKBIA) (Fig. 3b;
Additional file 4). Most genes were predicted targets
of predominantly miR-29a, miR-202, and miR-3277
(Additional file 4).
miRNAs that were up- and downregulated in PMECs
at 24 hpc with E. coli were negatively correlated with tar-
get genes that were also involved in negative regulation
of metabolic processes, transcription, gene expression,
biosynthetic processes, and regulation of transcription
from RNA polymerase II promoter (e. g., ATF7IP, BCOR,
BMP2, HEXIM1, ID3, MDM4, PPARG, RBM15, RNF2,
SP100, TLE1, and TRIM27) (Fig. 4a; Additional file 4).
Most genes were predicted targets of predominantly
miR-10a, miR-1934-star, miR-23a-star, miR-263a-star,
miR-289, miR-29a, miR-30b-star, miR-3216, miR-3277,
miR-34c, miR-363, miR-4592, miR-660, miR-92b, miR-
M9-3p, miR-rL1–34-5p, and miR894 (Additional file 4).
Molecular functions influenced by predicted target
genes of up- and downregulated miRNAs in PMECs at
24 hpc with E. coli included transcription repressor ac-
tivity (e. g., ARID5B, ATF7IP, ATXN1, BCLAF1, BMP2,
CREBZF, HEXIM1, PPARG, SP100, and TLE1); binding
of nucleotides, ribonucleotides, purine ribonucleotides,
purine nucleotides, adenyl ribonucleotides, and ATP (e. g.,
ABCA7, AKAP9, CAMKK2, CHD7, CLK1, FGFR2, FGFR3,
IGF1R, TOP1, and UBE2R2); RNA binding (e. g., ATXN1,
DDX18, DGCR8, EIF4E, LARP4, NOL6, OBFC2A,
RBM41, RBM5, and RPUSD4); chromatin binding (CDC6,
Table 1 Top 30 significantly DE miRNAs and their predicted
target genes from microarray analysis in PMECs at 3 hpc with
E. coli compared with unchallenged controls




Sequence (5′ - > 3′) Downregulated
target genes
miR-29b UAGCACCAUUUGAAAUCAGUGUU BCOR, KLHDC7A
miR-140 CAGUGGUUUUACCCUAUGGUAG RAB40B
miR-210 UUGUGCGUGCGACAGCGACUUC RAB40B
miR-101 UACAGUACUGUGAUAACUGAAG EML5, HELLS,
RBM12






let-7 g-star CUGUACAGGCCACUGCCUUGC DUSP6



















miR-4903 UACCCCGGUAGGCAUAGGUUG GLRX, IL1RAP,
MAP3K8, PLAUR










miR-2287 CUGGGACUGGUGGCAGCACUU CLDN1, ITGAV,
RNF19B
miR3949 UGAUGUUGAGGCAAAAAUGUAG CCDC152, RBM39,
RFX1
miR-885-3p AGGCAGCGGGGUGUAGUGGAUA BIRC3, DCUN1D3,
HIVEP2, IL10RB,
MAP3K8, TNFAIP3
miR-2518 UCGAGCAGCGGGUCGAUCCGAGC CYP1A1, JAG1
Table 1 Top 30 significantly DE miRNAs and their predicted
target genes from microarray analysis in PMECs at 3 hpc with
E. coli compared with unchallenged controls (Continued)
miR-3042 GAGGGCAGAUUAUUUCUGAUAC JAG1, LPIN1, YPEL2
miR-4031-5p CCCAAAGUGUCGGCGCAUAU SGSM1, TNFAIP3
miR-4317 ACAUUGCCAGGGAGUUU NFKBIA
miR-216b AAAUCUCUGCAGGCAAAUGUGA ETV5, PDLIM5




miR394b-star AGGUGGACAUAUUGCCAACA ITGAV, JAG1
miR-648 AAGUGUGCAGGGCACUGAU HIVEP2, IFNAR2,
JAG1, SGSM1
MiRNAs with p < 0.05 and fold change >1.5 or < −1.5 are listed and sorted by
fold change in descending order. TargetScan-predicted miRNA-mRNA pairs
showing negative correlation in expression profile and energy-value of at
least −25 kcal/mol
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CHD7, GLI3, HELLS, RNF2, SF3B1, TLE1, and TOP1);
and protein domain specific binding (BMP2, CLDN1,
ELMO1, FUT8, ID3, LUC7L, RHOQ, RIPK1, SFN, SP100,
SYK, and YWHAG) (Fig. 4b; Additional file 4). Most genes
were predicted targets of predominantly miR-10a, miR-
1280, miR-1934-star, miR-23a-star, miR-263a-star, miR-
363, miR-660, miR-92b, and miR894 (Additional file 4).
The number of target genes predicted for DE miRNAs
and involved in the regulation of biological processes or
Table 2 Top 30 significantly DE miRNAs and their predicted
target genes from microarray analysis in PMECs at 24 hpc with
E. coli compared with unchallenged controls




Sequence (5′ - > 3′) Downregulated
target genes








miR-29a UAGCACCAUUUGAAAUCGGUU CDC6, CYP26A1,
DNAJA1, EML5,
RNF2, TIMM44

















































Table 2 Top 30 significantly DE miRNAs and their predicted
target genes from microarray analysis in PMECs at 24 hpc with
E. coli compared with unchallenged controls (Continued)




















miR3949 UGAUGUUGAGGCAAAAAUGUAG CCDC152, RBM39,
RFX1,
miR-B8-5p CGCGGGCAAAAAAUCCAAUGGC BIRC3, MAP3K8,
PLXND1, RNF19B








miR-2779 AUAUCCGGCUCGAAGGACCA CLDN1, PLXND1
miR-4592 CCAGCGGCGGUGCCGUGAUGGCGA CLDN1, CEP68, CXCL2,
ITGB8, MDM4, RHOQ







miR-3277 UGGGCAUGUUUCUGAAAUUCGAU ARHGAP28, IFNAR2,
IL1A, PPARG
MiRNAs with p < 0.05 and fold change >1.5 or < −1.5 are listed and
sorted by fold change in descending order. TargetScan-predicted
miRNA-mRNA pairs showing negative correlation in expression profile
and energy-value of at least −25 kcal/mol
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molecular functions in PMECs is about two- to tenfold
higher at 24 hpc than at 3 hpc with E. coli, respectively.
Enriched KEGG pathways and canonical pathways of
predicted gene targets of DE miRNAs differ at 3 hpc
and 24 hpc
In KEGG analysis, target genes of mostly downregulated
miRNAs in PMECs at 3 hpc and 24 hpc with E. coli were
significantly enriched in pathways in cancer (e. g.,
BIRC3, BMP2, GLI3, ITGAV, NFKBIA, and PPARG) and
apoptosis (e. g., BIRC3, IL1A, and NFKBIA) (Fig. 5a).
miR-3277, miR-548u, and miR-885-3p were highly pre-
dicted to play important roles in regulating both KEGG
pathways (Additional file 5).
At 3 hpc with E. coli, target genes of downregulated
miRNAs were significantly enriched in cytokine–cyto-
kine receptor interactions (BMP2, IFNAR2, IL10RB, IL1A,
IL1RAP, and LIFR); nucleotide-binding oligomerization
domain (NOD)-like receptor signaling pathways (BIRC3,
NFKBIA, and TNFAIP3); and Janus kinase/signal trans-
ducers and activators of transcription (Jak-STAT) sig-
naling pathways (IL10RB, IFNAR2, JAK2, and LIFR)
(Fig. 5a). miR-202, miR-2262, and miR-885-3p were
highly predicted to play important roles in regulating
expression of genes that are involved in the three
named KEGG pathways. Furthermore, most genes
regulating cytokine signaling and Jak-STAT signaling
were highly predicted to be targets of miR-3277, miR-
648, miR-8-5p, and miR-890 (Additional file 5). Target
genes of predominantly downregulated miRNAs in
PMECs at 3 hpc with E. coli were significantly enriched in
canonical pathways such as IL-10 signaling (IL1A, IL10RB,
IL1RAP, and NFKBIA); NF-ĸB signaling (BMP2, IL1A,
MAP3K8, NFKBIA, and TNFAIP3); peroxisome proliferator-
activated receptor (PPAR) signaling (IL1A, IL1RAP, NFKBIA,
and PPARG); tumor necrosis factor receptor 2 (TNFR2)
signaling (BIRC3, NFKBIA, and TNFAIP3); and the role of os-
teoblasts, osteoclasts and chondrocytes in rheumatoid arth-
ritis (BIRC3, BMP2, IL1A, IL1RAP, and NFKBIA) (Fig. 5b).
miR-3277, miR-4317, miR-4903, miR-548u, and miR-885-3p
were highly predicted to be important for regulation
of most of the named canonical pathways (Additional file 5).
Target genes of predominantly downregulated miR-
NAs in PMECs at 24 hpc with E. coli were significantly
enriched in canonical pathways such as interferon
signaling (MX1, ISG15, STAT1, and TAP1); protein
Fig. 3 Top categories of biological processes and molecular functions regulated by predicted target genes of significantly DE miRNAs at 3 hpc
with E. coli. a Predicted target genes of upregulated (grey bars) and downregulated (black bars) miRNAs from PMECs at 3 hpc with E. coli were
significantly enriched in biological processes such as negative regulation of biosynthetic and metabolic processes, transcription, lipid storage, cell
differentiation, and regeneration. b Predicted target genes of up- and downregulated miRNAs from PMECs at 3 hpc with E. coli regulate molecular
functions such as cytokine receptor and transcription repressor activity, as well as binding of cytokines, chromatin, and heat shock proteins
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ubiquitination (PSMB9, BIRC3, DNAJA1, DNAJC11,
PSMD12, TAP1, UBE2R2, USP28, and USP46); glioma
invasiveness signaling (DIRAS3, FNBP1, ITGAV, and
RHOQ); myc-mediated apoptosis signaling (FAS, IGF1R,
SFN, and YWHAG); and Gq signaling (DIRAS3, FNBP1,
GNA14, HRH1, NFKBIA, and RHOQ) (Fig. 5b). miR-210,
miR-23a-star, and miR-324-5p were highly predicted to
play important roles in regulating most of the named
canonical pathways (Additional file 5).
Validation of selected miRNA expression by real time
quantitative PCR
Seven miRNAs (miR-210, miR-423-5p, miR-17-3p, miR-
193a-5p, miR-320, miR-339-5p, and miR-362) that were
DE in miRNA microarray analyses were selected for
validation by real time quantitative PCR (RT-qPCR).
MiRNA expression analyzed by RT-qPCR was in good
accordance with microarray data, as shown by similar
fold changes (FC) (Additional file 6). This suggested that
our microarray data were reliable, although we used
pools of samples for microarrays compared to individual
samples for qPCR.
Discussion
The role of miRNAs in innate and adaptive immunity of
the mammary gland is increasingly well described in dif-
ferent species, e. g. human, mice, and cattle. In pigs, the
miRNA role regulating inflammatory defense mecha-
nisms during microbial infection of the mammary gland
has not yet been described. Therefore, we used the pre-
viously described PMEC model [7] to analyze specific
pathogen defense mechanisms under standardized ex-
perimental conditions in vitro. To the best of our know-
ledge, this is the first study describing specific miRNAs
and their predicted target genes in PMECs after contact
with a potential mastitis-causing E. coli strain, indicating
Fig. 4 Top categories of biological processes and molecular functions regulated by predicted target genes of significantly DE miRNAs at 24 hpc
with E. coli. a Predicted target genes of upregulated (grey bars) and downregulated (black bars) miRNAs from PMECs at 24 hpc with E. coli were
significantly enriched in biological processes such as negative regulation of metabolic processes, transcription, gene expression, biosynthetic processes,
and regulation of transcription from RNA polymerase II promoter. b Predicted target genes of up- and downregulated miRNAs from PMECs at 24 hpc with
E. coli were significantly enriched in molecular functions such as transcription repressor activity, as well as binding of RNA, nucleotides, ribonucleotides,
purine ribonucleotides, purine nucleotides, chromatin, protein domains, ATP, and adenyl ribonucleotides
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the important roles of these cells in pathogen clear-
ance within the first cellular barriers of the porcine
mammary gland.
DE miRNAs that were identified in PMECs at 3 hpc
and 24 hpc with E. coli were analyzed together with our
previous mRNA expression profile and then inte-
grated based on pairwise correlations and computa-
tional target predictions.
Pathogen challenge interfered with many host cellular
processes, including modulating miRNA production,
which influences host cell physiology and defense. As
shown in this study, many miRNAs were significantly
upregulated in PMECs at 3 hpc and 24 hpc with E. coli.
Expression data showed that long incubation of PMECs
with heat-inactivated E. coli resulted in more DE miR-
NAs than short incubation. Early response of PMECs at
3 hpc with E. coli was followed by a late, more intensive
host response at 24 hpc, as indicated by an approxi-
mately two-fold increase of significantly DE miRNAs.
This is in accordance with our mRNA microarray ana-
lysis, which also identified a more intense host response
after long-term challenge with E. coli [7].
Approximately 46% and 17% of identified mRNAs are
predicted to be miRNA-regulated in PMECs at 3 hpc
and 24 hpc with E. coli, respectively. Some of the identi-
fied DE miRNAs have not yet been described in the
current literature. But based on our target prediction
analysis and existing literature, most of the identified DE
miRNAs likely play important roles in regulation of in-
nate immunity and cellular homeostasis of PMECs.
Among these, miR-101, miR-24-star, miR-30b-star, miR-
210, miR-34c, and miR-17-3p were significantly DE in
PMECs after E. coli challenge and are also affected
during host responses of human, mice, or cattle to LPS
Fig. 5 Top KEGG pathways and canonical pathways regulated by predicted target genes of significantly DE miRNAs at 3 hpc and 24 hpc with E.
coli. a Predicted target genes of predominantly downregulated (black bars), but also upregulated (grey bars), miRNAs from PMECs at 3 hpc and
24 hpc with E. coli were significantly enriched in KEGG pathways such as cytokine–cytokine receptor interactions, apoptosis, cancer pathways, NOD-
like receptor signaling pathways, and Jak-STAT signaling pathways. b Predicted target genes of downregulated miRNAs were significantly enriched in
canonical pathways such as IL10 signaling, NF-kB signaling, PPAR signaling, TNFR2 signaling, and the role of osteoblasts, osteoclasts, and chondrocytes
in rheumatoid arthritis in PMECs at 3 hpc with E. coli. Predicted target genes of up- and downregulated miRNAs were significantly enriched in canonical
pathways such as interferon signaling, protein ubiquitination, glioma invasiveness signaling, myc-mediated apoptosis signaling, and Gq signaling in PMECs
at 24 hpc with E. coli
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stimulus or E. coli infection [12, 20–24]. In addition,
some DE miRNAs in our analysis play pivotal roles in
regulation of host defenses against other bacterial
infections (miR-23a-star, miR-125-star, and miR-128)
[12, 25, 26]; viral infections (miR-29a, miR-505, and
miR-423-5p) [27–29]; parasitization (miR-8-star) [30];
and inflammatory bowel disease (miR-10a and miR-
5128) [31, 32]. Furthermore, miR-101, miR-29b, miR-
10a, miR-17-3p, and miR-92b were DE expressed in
PMECs after pathogen challenge and are important reg-
ulators in bovine (endo-) metritis [33]. In addition, miR-
484, miR-660, miR-34c, miR-339, miR-193a-5p, and
miR-362 have regulatory functions in breast cancer pro-
gression [34–39] and were also deregulated in PMECs
after pathogen challenge. Likewise, some miRNAs that
were DE in PMECs at 3 hpc and 24 hpc with E. coli are
potential regulators of genes that were enriched in
KEGG pathways, such as cancer-related or apoptosis
pathways. Therefore, a deregulation of growth regulation
or an alteration of cellular physiological processes such
as cell proliferation, cell death and repair of genes in
PMECs by E. coli infection is assumed, which might play
a pivotal role in the genesis of PDS.
Staedel and Darfeuille [25] reported that recognition
of intruding pathogens by PAMPs — such as
membrane-associated TLRs and cytoplasmic NOD-like
receptors — is essential for subsequent activation of
innate and adaptive immunity, mostly stimulated by
NF-ĸB signaling. Accordingly, we identified miR-202,
miR-2262, miR-4031-5p, miR-4317, miR-548u, and miR-
885-3p as potential regulators of target genes that are
enriched in NOD-like receptor signaling pathways in
PMECs, referring to recognition of E. coli. In contrast,
the TLR signaling pathway was not identified as one of
the top enriched canonical pathways in PMECs after
pathogen challenge as discuss in our previously study
[7]. It is possible that the preparation of heat kill parti-
cles somehow removed TLR agonists from the particles
from pMECs but not from bMECs [40]. This is still lack
of knowledge in this field of experiment. However, miR-
101, miR-125-star, miR-8-star, and miR-29a were DE in
PMECs after pathogen challenge and are involved in
TLR signaling [20, 25, 30].
MiRNAs can interact with several signaling molecules,
such as cytokines, chemokines, and transcription factors,
and therefore influence various signaling pathways and
cellular processes [25]. In our study, miR-202, miR-3277,
miR-4903, miR-648, miR-8-5p, miR-885-3p, and miR-
890 were identified to play critical roles in regulation of
genes that control cytokine receptor activity and cyto-
kine binding. Additionally, some miRNAs that were DE
in PMECs after pathogen challenge are known to regu-
late genes that are involved in NF-ĸB signaling (miR-210
and miR-23a-star) [41, 42] or production of cytokines
IL-6, TNF-alpha, IL-1 beta, and IL-10 (miR-30b-star,
miR-210, miR-17-3p, miR-23a-star, miR-24-star, miR-
29b, miR-125-star, miR-1934-star, and miR-320) [21, 22,
24, 42–47]. Furthermore, our analysis identified pre-
dicted target genes of DE miRNAs in PMECs at 3 hpc
with E. coli that are enriched in top canonical pathways
such as IL-10 signaling, PPAR signaling, NF-ĸB signal-
ing, TNFR2 signaling, or arthritis-associated roles. These
signaling pathways are important for fast pathogen rec-
ognition and effective nonspecific removal of infectious
agent as well as moderate the inflammatory response to
limit tissue damage of the host. At 24 hpc of PMECs
with E. coli, predicted target genes of DE miRNAs were
enriched in top canonical pathways such as interferon
signaling and protein ubiquitination, which were also
significantly enriched in our previous mRNA analysis of
pathogen-challenged PMECs [7]. In this late immune re-
sponse phase these signaling pathways can increase
host-defense by activation of immune cells and regula-
tion of a variety of fundamental cellular processes.
Altogether, the number of target genes predicted for
DE miRNAs and involved in regulation of biological
processes or molecular functions in PMECs was two- to
tenfold higher at 24 hpc than at 3 hpc with E. coli.
In addition to our target prediction analysis, current
literature suggests that some DE miRNAs in PMECs also
regulate genes involved in Jak-STAT signaling (miR-125-
star, miR-289, miR-22-star, and miR-23a-star) [45, 48–50];
interferon signaling (miR-29a) [28]; MAPK signaling
(miR-289, miR-324-5p, and miR-193a-5p) [48, 51, 52];
TGF signaling (miR-125-star, miR-324-5p, miR-193a-5p,
and miR-505) [45, 51–53]; PTEN/Akt signaling (miR-92b)
[54]; and Wnt signaling (miR324-5p and miR-193a-5p)
[51, 52]. Interaction of signaling molecules that are in-
volved in these pathways seems to be important to balance
pro- and anti-inflammatory processes and to ensure im-
mune homeostasis as well as host protection [55]. This is
confirmed by our results, as some miRNAs that were DE
in PMECs after pathogen challenge play crucial roles in
innate and adaptive immune responses (miR-101, miR-
125-star, miR-423-5p, miR-10a, miR-23a-star, miR-1934-
star, miR-29a, miR-29b, miR-24-star, let-7 g-star, miR-320,
miR-17-3p, miR-324-5p, and miR-8-star) [20, 25, 27, 31,
42, 46, 56–64] as well as negative feedback regulation of
inflammation (miR-210 and miR-17-3p) [22, 62].
Our target prediction analysis revealed several DE
miRNAs as potential regulators of genes that control
biosynthetic, metabolic, and transcriptional processes in
PMECs at 3 hpc as well as 24 hpc with E. coli. In
addition, some DE miRNAs in our study are known to
target genes involved in regulation of cell adhesion/
cytoskeleton (miR-17-3p, miR-339, and miR-8-star)
[62, 65, 66]; cell survival/DNA repair (miR-324-5p, miR-
8-star, miR-890, miR-885-3p, and miR-363) [63, 65, 67–70];
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catabolism (miR-320 and miR-140) [44, 47, 70]; migration/
invasion/tumorigenesis (miR-339, miR-193a-5p, miR-362,
miR-125-star, miR-92b, miR-324-5p, miR-320, miR-202,
miR-371, miR-125a-3p, and miR-140) [37–39, 45, 54, 63,
71–75]; cellular transport (miR-10a and miR-5100 [60, 76];
proliferation/differentiation/cell cycle/growth/development
(miR-484, miR-34c, miR-339, miR-193a-5p, miR-362, miR-
125-star, miR-92b, miR-24-star, miR-10a, miR-324-5p, miR-
363, miR-320, miR-202, miR-371, miR-125a-3p, miR-140,
miR-5100, miR-128, miR-216b, miR-4423-3p, and miR-
320b) [34, 36–39, 45, 54, 58, 60, 63, 67, 71–80]; and apop-
tosis/ autophagy/ phagocytosis (miR-30b-star, miR-125-star,
miR-324-5p, miR-505, miR-92b, miR-24-star, miR885-3p,
miR-320, miR-128, miR-216b, miR-320b, miR-125a-3p,
miR-363, and miR-423-5p) [43, 45, 51, 53, 54, 58, 69, 71,
77, 78, 80–84]. These results are consistent with our
mRNA study, in which pathogen challenge of PMECs re-
sulted in DE genes that regulate cellular growth, prolifera-
tion, development, cell death, and survival [7]. All
these processes are physiologically significant for de-
termining epithelial cell fate, ensuring epithelial cell
functions, and fine-tuning epithelial immune responses
against infection [85].
Conclusions
Combined with current literature, our data show that
many functions of several miRNAs seem to be highly
conserved across species. However, while many miRNAs
can have similar functions, specific miRNAs also can
have different functions in PMECs. We suppose the
identified miRNAs have critical roles in pathogen recog-
nition and initiation of local and systemic immune re-
sponses in PMECs. Altogether, our results strongly
suggest that DE miRNAs in PMECs contribute to patho-
genesis of porcine mastitis induced by E. coli. The detec-
tion of several known and novel miRNAs in context
with predicted target genes in PMECs is another indica-
tor for the immune competence of these cells and pro-
vides a strong impulse to further examine porcine
mammary gland immune defense mechanisms.
Methods
Cell culture and pathogen challenge
PMECs are originated from our previous study [7].
Therefore, cell cultures were established from mammary
glands of three lactating sows of commercial herds.
Animal care and tissue collection was performed in
compliance with the German Law of Animal Protection.
The experimental protocol was approved by the Animal
Care Committee of the Leibniz Institute for Farm Animal
Biology, Dummerstorf, Germany. Animals were exsangui-
nated following electronarcosis and dissected. Cryopre-
served mammary epithelial cells were thawed and
resuspended in complete medium consisting of Dulbecco’s
Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/
F12, PAN Biotech, Aidenbach Germany), 10% fetal bovine
serum (FBS, PAA, Cölbe, Germany), 1% Antibiotic/Anti-
mycotic Solution (APS, 10,000 U/ml penicillin, 10 mg/ml
streptomycin sulphate, 25 μg/ml amphotericin B, PAA),
10 μg/ml insulin (Sigma-Aldrich, Taufkirchen, Germany)
and 1 μg/ml hydrocortisone (Sigma-Aldrich).
E. coli strain (gMEc240, sequence type 101, phy-
logroup B1, C+) used for this study is an isolate from
milk of PDS-positive sows and was provided by the
Institute of Microbiology and Epizootics, Department of
Veterinary at the Freie Universität Berlin, Berlin,
Germany. E. coli was grown in brain-heart-infusion-
broth (BHB, Oxoid, Wesel, Germany) at 37 °C to the
logarithmic phase of culture growth (Optical Density at
600 nm [OD600] 0.5 ~ 5 × 10
7/ml). Bacteria were heat-
inactivated at 80 °C for 1 h, spun down at 3000 rpm for
15 min, washed twice with Dulbecco’s Modified Eagle
Medium/Nutrient Mixture F-12 (DMEM/F12) medium
and resuspended herein at a density of 1 × 108/ml.
The experimental design was identical with the pro-
cedure as described before [7]. Briefly, approximately
4.4 × 105 cells from each 3 individual (3 biological repli-
cates) were seeded and cultured in collagen-coated
6-well plates (1:10 collagen R in destilled water, Menal,
Emmendingen, Germany) in complete medium without
APS (three technical replicates per individual and treat-
ment condition). After 24 h, medium was changed.
Within the next 48 h after seeding, cells reached about
90% confluency. Then PMECs were challenged with 107/
ml heat-inactivated E. coli for 3 h and for 24 h. Unchal-
lenged cells were used as a negative control. After incu-
bation periods, medium was discarded, and cells were
washed three times with phosphate buffered saline (PBS,
PAA) to remove the bacteria. Afterwards, cells were
collected for isolation of total RNA and small RNA.
RNA isolation
Total RNA was isolated from each of the 27 samples
using the TRI® reagent (Sigma-Aldrich) and extracted
with phenol-chloroform according to the manufacturer’s
instructions. Isolated RNA was purified using RNeasy
Mini Kit (Qiagen, Hilden, Germany), and contaminating
DNA was removed by DNase I digestion (Qiagen). Isola-
tion and enrichment of small RNA was performed by
using a miRNeasy kit and an RNeasy MinElute Cleanup
kit (both from Qiagen) according to the manufacturer’s
protocols. RNA integrity and quantity were assessed
with an Agilent 2100 Bioanalyzer using an RNA 6000
Nano kit for total RNA and a separate kit for small RNA
(both from Agilent Technologies Inc., Santa Clara, CA,
USA). The mean RIN and standard deviation for the
samples used in the analysis was 9.72 ± 0.24.
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microRNA microarray analysis and statistics
microRNA expression profiling was performed using
hybridization to GeneChip miRNA 3.0 Arrays (Affymetrix
Inc., Santa Clara, CA, USA) according to the manufacturer’s
recommendations. The array has a very high sensitivity and
specificity and offers 100% coverage of miRBase 17
(www.mirbase.org) by a one-color approach. In addition, the
array contains 16,772 entries representing hairpin precursor,
total probe set 19,724 for detection of 1733 mature miRNA,
2216 human snoRNA and scaRNA products in 153 species,
and provides a greater than 3-log dynamic range with higher
than 95% reproducibility and 85% transcript detection at 1.0
amol for a total RNA input of 130–500 ng.
In total 27 small RNA samples were isolated. Equiva-
lent amount of small RNA from three technical repli-
cates per individual was pooled. In total 9 pooled
samples of small RNA were used for further experiment.
An amount of 200 ng of each small RNA sample pool
was labeled with the FlashTag Biotin HSR RNA Labeling
kit (Genisphere, Hatfield, PA). Labeled RNA was hybrid-
ized for 16 h to the miRNA arrays according to the
manufacturer’s recommendations. A total of nine micro-
arrays were obtained. Afterwards, arrays were washed
and stained in a Fluidics Station 450 (Affymetrix), and
scanned on the G3000 GeneArray Scanner (Affymetrix).
Pre-processing of raw expression data was done using
the Expression Console™ software (Affymetrix). Robust
multi-array average (RMA) background correction, log-2
transformation, quantile normalization and statistical
analysis were performed using SAS 9.4 containing JMP
Genomics 7 (SAS Institute, Cary, NC, USA). The
ANOVA procedure in JMP genomics 7 was performed
to determine relative changes in miRNA levels, including
effects mediated by 3 experimental group (before (0 h)
and after challenged (3 h and 24 h) with each 3 repli-
cates of each experimental group. Alterations in tran-
script abundances were considered to be statistically
significant at p < 0.05. Subsequently, data were filtered
by fold change >1.5 or < −1.5. The miRNA microarray
data were deposited in the Gene Expression Omnibus
(GEO) public repository (GEO accession number
GSE88870: GSM2350436 -GSM2350444).
Prediction and functional annotation of miRNA target genes
We used our previous microarray-based mRNA expres-
sion data to integrate with the DE miRNAs and scan for
potential target genes [7]. TargetScan was used to detect
predicted target genes based on seed complementarity
on both 3′-, 5′-UTR and coding sequences of the por-
cine mRNA sequences (Sus scrofa 10.2 download from
NCBI: http://www.ncbi.nlm.nih.gov/ on 1.9.2015) and
miRNA sequences [86]. RNAhybrid software (http://
bibiserv.techfak.uni-bielefeld.de/rnahybrid) was used for
direct prediction of multiple, energetically most favorable
potential binding sites of our differentially expressed miR-
NAs [87, 88]. microRNAs were tested due to the following
default parameters: (i) number of hits per target, 1; (ii) en-
ergy cutoff, −25 kcal/mol; (iii) maximal internal or bulge
loop size per side, 4. Pearson correlation of miRNA and
mRNA expression levels was calculated based on the pre-
dicted miRNA-mRNA relationships. We selected only
negative correlation pairs of miRNA-mRNA with p < 0.05.
The most affected biological processes and molecular
functions as well as enriched KEGG pathways of predicted
target genes were determined using the Database for
Annotation, Visualization and Integrated Discovery 6.7
(DAVID) [89]. In addition, the top canonical pathways,
miRNA targets are involved in, were identified using the In-
genuity Pathway Analysis software (p ≤ 0.05, Fisher’s exact
test; IPA, Ingenuity Systems, Redwood City, CA, USA).
Validation of microRNA microarray results by Fluidigm
real-time quantitative PCR
Transcript levels of seven miRNAs were measured by
RT-qPCR using the Fluidigm BioMark HD System
(Fluidigm Corporation, San Francisco, CA, USA). First,
200 ng of miRNA was converted to cDNA using the
Megaplex RT Primers, Human Pool Kit v2.1/v3.0
(Thermo Fisher Scientific, Waltham, MA, USA). The
pre-amplification sample mixtures were prepared con-
taining 1.25 μl of diluted cDNA, 2.5 μl of 2× Taqman
pre-amplification master mix (Applied Biosystems,
Waltham, MA, USA), and 0.5 μl of the primer pool
(200 nmol each primer/μl; Promega, Mannheim,
Germany; Additional file 6). The pre-amplification PCR
program consisted of a 10 min 95 °C denaturation step
and 14 cycles of 15 s at 95 °C and 4 min at 60 °C. The pre-
amplified reactions were diluted 10 times in Tris-EDTA
(TE) buffer. Five microliters from sample mix containing
pre-amplified cDNA, pooled primers and EvaGreen mas-
ter mix (Fluidigm BioMark) were combined as outlined in
the manufacturer’s protocol. The 48.48 dynamic array chip
(Fluidigm Corporation) was first primed with control line
fluid and then loaded with the sample and assay mixtures
via the appropriate inlets using an IFC controller. The
array chip was placed in the Fluidigm BioMark Instru-
ment for PCR at 95 °C for 10 min, followed by 30 cycles at
95 °C for 15 s and 60 °C for 1 min. The samples were in-
vestigated in duplicate, and data were analyzed with RT-
PCR analysis software in the BioMark HD instrument.
The mean Ct values of the different miRNAs were nor-
malized to U6 snRNA and miR-24-3p (internal controls),
and then subjected to analysis using the 2−ΔΔCt method
[90]. Both internal controls were selected, because their
transcript levels were most stable over time and treatment
in PMECs. In addition, U6 snRNA is known as one of the
most commonly used internal control for the normalization
of miRNA qPCR data.
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